A 67-year-old man visited our hospital for the treatment of gastric carcinoma. Endoscopic mucosal resection was performed, however, histological examination of the resected specimen revealed tumor invasion to the submucosal layer with vessel invasion. Immunohistological studies were carried out on resected specimens and part of the cancerous lesion showed a positive reaction for alpha-fetoprotein (AFP), but the serum AFP level was normal. Additional distal gastrectomy with lymph node dissection revealed lymph node metastasis although there was no apparent finding of lymph node swelling by preoperative diagnostic imaging. This patient remains alive without disease for 3 years after surgery. 
Introduction
Alpha-fetoprotein (AFP)-producing gastric carcinoma (AFPGC) accounts for only 2-9% of gastric cancer (1) . In AFPGC patients, liver metastases are often noted (2) and the tumor often has progressed to advanced gastric carcinoma at the time of diagnosis. In Japan, AFP-producing early gastric carcinoma (AFPEGC) is extremely rare and only 23 cases have been reported in the past 15 years (1) (2) (3) (4) (5) (6) (7) (8) . Herein we report the case of a man diagnosed with seronegative AFPEGC treated with endoscopic mucosal resection (EMR) and additional surgery.
Case Report
A 67-year-old man visited our hospital for treatment of gastric cancer in September 2000. No specific family or past medical history was identified. Routine hematological examination and biochemical tests were within normal limits. In tumor marker examinations, carbohydrate antigen 19-9 was negative, however, carcinoembryonic antigen (CEA) was slightly high at 5.2 ng/ml (NR <5 ng/ml). Alphafetoprotein (AFP) was within normal limits at 3.4 ng/ml (NR <10 ng/ml).
Endoscopic examination of the upper digestive tract revealed a protruding lesion, about 25 mm in diameter, in the middle third of the greater curvature of the stomach (M area) (Fig. 1) . The biopsy specimen obtained from the protruding lesion revealed moderately-differentiated adenocarcinoma. Examination by computed tomography (CT) revealed no abnormalities in the abdomen. There was no apparent finding of distant metastasis. Endoscopic ultrasonography (EUS) with a miniature probe of 20 MHz frequency using the water filling method revealed that the third layer of the gastric wall was uneven (Fig. 2) . Thus we could not deny that the tumor had submucosal invasion. However, EUS was not sensitive enough to evaluate invasion to the submucosa in the present patient because this lesion was an elevated tumor and it was difficult to show the depth of the tumor by EUS.
The present patient was eager to undergo endoscopic resection. The patient underwent EMR for treatment under informed consent. EMR using an insulated-tip diathermic knife (IT-EMR) was performed as previously described (9) . The protruding lesion was resected completely with a safe lateral and vertical margin, measuring 26×25 mm in size. Histo-logical examination of the protruding lesion revealed tumor invasion to the submucosal layer ( Fig. 3A) with vessel invasion (Fig. 3B) . The tumor was diagnosed as moderatelydifferentiated adenocarcinoma with submucosal invasion, ly2, and v1. The tumor revealed a solid papillary structure and included abnormal cells with clear cytoplasm and hyperchromic round nuclei (Fig. 4) . Thus, the tumor was suspected as AFPGC. Immunohistological studies were carried out for the resected specimens and the cancerous lesion showed a positive immunohistochemical reaction for AFP (Fig. 5) . The malignant cells that invaded to the submucosal layer represented positive immunoreaction for AFP, however, tumor cells in the vessels were negative immunoreaction for AFP. AFP-producing tissue accounted for about 5% of this tumor.
Additional distal gastrectomy with radical lymph node dissection was carried out. Histological examination of the resected specimen revealed an ulcer after EMR and malignant tumor cells were removed. However, lymph node metastasis was seen at #3, 7, and 8a according to the Japanese classification of gastric carcinoma (10) 
Discussion
Generally, the prognosis for AFPGC is poor, because in such patients, liver metastases are often noted at the time of diagnosis (2) . Although the tumor is an early gastric cancer, AFPGC tends to show liver metastasis, blood vessel invasion or lymphatic vessel invasion (4) . In the present case, additional surgery was necessary after EMR because of the submucosal invasion and vessel invasion of the EMR resected specimen.
A review of the English and Japanese literature revealed 23 cases of AFPEGC reported in Japan in the past 15 years. Table 1 shows the 24 cases of AFPEGC reported in Japan in the past 15 years, including the present case (1) (2) (3) (4) (5) (6) (7) (8) . The male to female ratio was 17 : 7, the mean age was 64.4 years (range, 41 to 79 years), and the primary symptom at the time of onset was epigastralgia (29.2%). There were 10 asymptomatic patients (41.7%). AFPEGC sites were studied, and 15 of 24 patients (62.5%) had lesions in the lower third area (L area). As for gross type, IIa+IIc, IIc, IIa and I were most frequently observed in that order. IIa+IIc, IIc, IIa and I were macroscopically observed in 10, 8, 2, and 2 patients, respectively. Liver metastasis was seen in 2 patients (8.3%) and lymph node metastasis was seen in 18 (75.0%) of 24 patients at diagnosis, as seen in Table 1 AFPEGC even if lymph node swelling is not seen on diagnostic imaging, as in the present case. As to therapy, 10 of 24 patients in Table 1 received surgical resection and adjuvant chemotherapy. The remaining 14 patients were treated with surgical operation and without chemotherapy. Among the 24 patients, in only the present case EMR was used to remove the tumor (Table 1) . In the present case, the serum AFP level was within normal limits. There have been only 5 cases of seronegative AFPEGC, including our case in Table 1 . In the present case, although the histological diagnosis of the resected tumor was moderately-differentiated adenocarcinoma, the tumor had abnormal cells with clear cytoplasm and hyperchromic round nuclei. These pathological findings were the clues to the diagnosis of AFPGC. We speculate that seronegative AFPEGC means AFPGC that is diagnosed before serum AFP elevation. Because there were some cases whose resected specimen proved to be AFPGCs after postoperateive serum AFP elevation, although the serum AFP levels were normal before operation (2, 4, 5) . However, it is important that physicians consider the possibility of AFPGC in the pathological study before operation or immediately after operation. Because the prognoses of the patients whose resected specimen proved to be AFPGCs after recurrence were poor as Umekawa (3) or Suganuma (4) reported. Although the tumor is an early gastric cancer, AFPGC tends to show liver metastasis, blood vessel invasion or lymphatic vessel invasion and often recurs in the liver or lymph nodes after operation. Thus we think that adjuvant chemotherapy is necessary for AFPEGC even if the serum AFP level is not so high. If such patients are diagnosed as AFPGC before operation or immediately after operation, they are able to undergo adjuvant chemotherapy quickly. But the efficacy of adjuvant chemotherapy is not proved although there are some reports describing the patients with AFPGC treated with adjuvant chemotherapy (1, 5, 7) . Moreover, a standardized chemotherapy for AFPGC has not been established yet. Shimada et al recently reported two cases with AFPGC with liver metastases successfully treated with irinotecan (CPT-11) (100 mg/body) plus lowdose cisplatin (10 mg/body) and described that this combination might be worth trying as first line chemotherapy for this disease (11) . We also recently reported a case with unresectable AFPGC considered to have achieved complete response (CR) by CPT-11/mitomycin C chemotherapy (12) . Further studies on the effective chemotherapy for AFPGC are certainly required. It is important to determine the necessity of adjuvant chemotherapy for AFPEGC individually at the moment because several cases that did not undergo adjuvant chemotherapy have been reported. After all, no additional chemotherapy was performed in the present case because this patient refused adjuvant chemotherapy. We should be attentive to recurrence and carefully follow the serum AFP level; this patient will undergo chemotherapy if the serum AFP level increases. We should be aware of the clinical presentation of seronegative AFPEGC, and physicians must always consider the possibility of AFPGC in the pathological study of gastric carcinoma.
In conclusion, we report a case of seronegative AFPEGC treated with EMR and additional surgery. Although the tumor invasion was limited to the submucosal layer and there was no apparent finding of lymph node swelling by the diagnostic imaging, additional surgery revealed lymph node metastasis. The patient has been under close periodic observation, and there has been no evidence of disease for 3 years after surgery.
